Mano Michael
SEC CIK 1837741 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | SVP, GC, Sec | 94.4K | — | $107.8K | 18 | 2022-02-28 | 2026-05-14 |
Most active insiders at KPTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| 2 | Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| 3 | Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| 4 | Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| 5 | Mano Michael | SVP, GC, Sec | — | $35.7K |
| 6 | Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| 7 | Abate Kristin | CAO | — | $10.0K |
| 8 | Su Zhen | Dir | — | — |
| 9 | Oliger Christy J. | Dir | — | — |
| 10 | Schor Chen | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 16:02 | 2026-05-13 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | EVP, CLO, Sec | A - Grant | $0.00 | +700 | 94.7K | +0.7% | $0 | |
| 2026-05-15 16:02 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | EVP, CLO, Sec | S - Sale | $9.50 | -266 | 94.4K | -0.3% | -$2,527 | |
| 2026-03-03 | 2026-03-02 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | EVP, CLO, Sec | S - Sale | $9.41 | -3,526 | 94.0K | -4% | -$33.2K | |
| 2026-02-03 | 2026-01-31 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | EVP, CLO, Sec | A - Grant | $0.00 | +32.4K | 97.5K | +50% | $0 | |
| 2025-10-16 | 2025-10-15 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +43.6K | 65.1K | +204% | $0 | |
| 2025-09-16 | 2025-09-12 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +612 | 21.7K | +3% | $0 | |
| 2025-09-16 | 2025-09-15 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | S - Sale | $6.43 | -234 | 21.4K | -1% | -$1,505 | |
| 2025-03-06 | 2025-03-04 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | S - Sale | $6.29 | -2,793 | 21.0K | -12% | -$17.6K | |
| DM | 2025-03-04 | 2025-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +5,583 | 21.6K | +35% | $0 |
| 2024-09-05 | 2024-09-04 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | S - Sale | $0.72 | -3,971 | 273.9K | -1% | -$2,859 | |
| M | 2024-03-04 | 2024-02-29+ | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | S - Sale | $1.18 | -20.5K | 277.9K | -7% | -$24.1K |
| 2024-02-29 | 2024-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +147.0K | 298.4K | +97% | $0 | |
| 2024-01-25 | 2024-01-24 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +9,167 | 151.4K | +6% | $0 | |
| 2023-09-05 | 2023-09-01 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | S - Sale | $1.33 | -3,888 | 142.2K | -3% | -$5,171 | |
| 2023-03-02 | 2023-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +70.0K | 153.0K | +84% | $0 | |
| 2023-03-02 | 2023-03-01 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | S - Sale | $3.03 | -6,878 | 146.1K | -4% | -$20.8K | |
| D | 2022-09-01 | 2022-08-31 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +20.0K | 83.0K | +32% | $0 |
| D | 2022-03-02 | 2022-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +63.0K | 63.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations